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Abstract
Quantifying tetrodotoxin (TTX) has been a challenge in both ecological and medical research due to the cost, time
and training required of most quantification techniques. Here we present a modified Competitive Inhibition
Enzymatic Immunoassay for the quantification of TTX, and to aid researchers in the optimization of this technique
for widespread use with a high degree of accuracy and repeatability.
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Background
Tetrodotoxin (TTX) is a low molecular weight neuro-
toxin that blocks the pore region of voltage-gated
sodium channels [1-3] and is found in a wide array of
taxa [reviewed by [4]]. The diversity of species with
TTX raises questions about the ecological functions and
evolutionary implications of TTX [reviewed by [5]].
Further, TTX is of concern to human health as fugu
and marine gastropods are commonly consumed in
Asian countries [e.g. [6,7]]. Therefore, quantification of
TTX is of high importance for multiple fields of
research. Traditional approaches for quantifying TTX
have limited efficiency and practicality. For example,
one common method of quantifying TTX is High Per-
formance Liquid Chromatography [HPLC; reviewed by
[8,9]]. HPLC is an effective means of measuring TTX
but is costly, time consuming, and requires special train-
ing and expensive equipment.
A more efficient method of quantifying TTX is to use
an immunoassay specific to tetrodotoxin. Several meth-
ods for Competitive Inhibition Enzymatic Immunoassays
(CIEIA) or other competitive enzyme immunoassays
(EIA) exist [e.g. [10-13]]. However, in our experience pre-
viously published immunoassay methods are not replic-
able without detailed knowledge of EIA procedures,
contain errors, or report suboptimal concentrations of
reagents. Here, we report a modified CIEIA procedure
that employs a commercial monoclonal antibody specific
to TTX for identification and quantification. Addition-
ally, we report the repeatability between plates within a
lab. This method is flexible and adaptable and could
identify and quantify TTX in a range of medical or ecolo-
gical studies using readily available and more affordable
lab equipment and reagents.
Results and discussion
This assay is highly repeatable, sensitive, and an accurate
means of quantifying TTX (Table 1). The minimum
limit of detection was 10 ng/ml (13; Figure 1a), and the
linear range of the standard curve was 10-500 ng/mL
with r
2 = 0.9759 (Figure 1b). In the linear range, the
average intraplate CV for replicates was 6.38 and 7.72%,
while the average interplate CV was 8.88%. The concen-
tration of TTX at which 50% of the anti-TTX was inhib-
ited from binding was ~75 ng/mL.
This CIEIA procedure allows for broader study of
TTX-bearing organisms where a high sample volume
can be screened with relatively little expense ($0.32 per
sample vs. $12.00 per sample with HPLC [excluding
equipment and labor]), time (7 hours vs. 48-96 hours
for HPLC for 24 samples), and technical expertise. How-
ever, because TTX analogs cannot be identified with this
technique, we recommend that data be augmented by
HPLC or GC-MS services for a few representative
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TTX congeners has shown that they are specific to TTX
and do not bind to these congeners [12].
Screening organisms that have yet to be tested for
TTX will further our understanding of the role of TTX
in ecological systems and evolution. Furthermore, this
assay could facilitate rapid pathology tests in human
poisoning cases that can be conducted at a wider array
of research/medical facilities. Modification of existing
methods was necessary to eliminate non-specific binding
where possible, which is important for accurate quantifi-
cation and interpretation of the results. The low varia-
bility between plates inherent to this method
demonstrates that this technique is sufficiently repeata-
ble to be widely used in a variety of medical and ecolo-
gical studies.
Conclusions
The methodology presented here modifies and refines
previous methodology (Kawatsu et al. 1997; Lehman
2007; Raybould et al. 1992; Tao et al. 2010) in order to
make CIEIA techniques for quantifying TTX more
feasible for researchers that do not routinely perform
such techniques or have access to specialized equipment
(e.g., HPLC). Additionally, this CIEIA technique is more
sensitive to TTX detection than HPLC from previously
reported analyses [14,15]. This immunoassay has been
proven useful in quantifying TTX in newts of the genus
Taricha [16], and has quantified concentrations within
the expected range of individuals quantified using HPLC
previously (unpublished data). Furthermore, these meth-
ods provide the necessary methodology for eliminating
issues with nonspecific binding that may occur with the
technique.
Methods
Conjugate preparation
Conjugate preparation is significantly modified from
previous work [11,12]. Specifically, TTX binds to Bovine
Serum Albumin (BSA; Sigma; A7906-50 G) with formal-
dehyde and the BSA will tether TTX (a small hydrophi-
lic molecule) to the plate. Because the commercial anti-
TTX antibodies were created against a keyhole limpet
cyanin (KLH) conjugate, the antibodies do not cross-
react with BSA in the final assay [12]. Seven-hundred
μL TTX (Sigma; T5651) at 1 mg/mL, 300 μLs o d i u m
acetate buffer (1 N; adjusted to pH 7.4 using 0.05 N
acetic acid; Sigma; S7670), 179 μLo fB S Aa t3 3 . 6m g /
mL, and 41 μL of 37% formaldehyde (Fisher Scientific;
AC11969) are added drop-wise to an amber glass vial
(conjugate is light sensitive), in that order, and vortexed.
TTX is soluble at a pH of 4-5, however previously
reported methodology states that TTX should be dis-
solved at a pH of 7.4 in sodium acetate buffer [11,12].
We utilized1 mg TTX lyophilized in 5 mg citrate buffer
and dissolved in 1 ml of ddH2O, which yielded the
appropriate pH, with no consequences to the efficacy of
Table 1 Comparisons of the calculated concentrations
from two different plates run the exact same way.
Concentration
1
(ng/ml)
Concentration
2
(ng/ml)
Mean
(ng/
ml)
Standard
Deviation
CV
(%)
Percent
Difference
104.37 107.72 106.05 2.37 2.23 3.16
72.77 74.67 73.72 1.34 1.82 2.57
50.22 44.93 47.58 3.74 7.86 11.12
23.87 23.13 23.50 0.52 2.23 3.15
10.31 10.93 10.62 0.43 4.10 5.80
Actual standard concentrations were 100, 75, 50, 25, and 10 ng/mL from top
to bottom, and were made for each plate independently
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Figure 1 Tetrodotoxin standard curves.( a) Standard curve of tetrodotoxin using concentrations of 100,000 ng/mL through 1 ng/mL. Each
sample was run in triplicate and all points are displayed to demonstrate variation between replicates. (b) Linear portion of standard curve (±
SEM). Linear range is between 10 and 500 ng/mL.
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in a shaker for three days at 37°C. Following incubation,
the solution is transferred to dialysis tubing and dialyzed
over a three day period at 4°C against four equally
spaced 1 L-changes of phosphate buffered saline (PBS;
Fisher Scientific; BP665-1). The concentration is then
determined by spectrophotometry (NanoDrop ND-1000
Spectrophotometer; at 280 nm). Finished conjugate may
be stored at 4°C and does not need to be lyophilized [as
in [13]].
Conjugate optimization
Optimal conjugate concentration is determined by run-
ning plates of standard curves with serial dilutions of
the conjugate. Excessively concentrated conjugate results
in high variation due to nonspecific binding [17]. Others
[11,12] reported 2 μg/mL concentrations for anti-TTX
antibodies (Hawaii Biotech) and 10 μg/mL BSA-TTXF
conjugate to coat the plate. We found that using a 2 μg/
mL solution of conjugate and consequently, a lower
concentration of antibodies, can be used saving materi-
als, eliminating nonspecific binding, decreasing variation,
and improving the fit and accuracy of the standard
curve. For each new lot of antibody purchased and used,
the appropriate concentration of antibodies will have to
be optimized using standard solutions of TTX and test-
ing serially diluted anti-TTX antibodies. Both primary
and secondary antibodies can be stored at 4°C or -20°C
between uses.
Extraction of TTX and preparation of standards
TTX is extracted by previously described methods [18].
Briefly, filtrates may be stored at -80°C for up to 5 yr. with-
out degradation of TTX (CT Hanifin pers comm.). Stan-
dards are prepared using 1 mg TTX lyophilized in citrate
buffer (Ascent Scientific; Asc-055) dissolved in 1 mL of a
1% solution of BSA diluted in PBS. The linear range of the
curve is quite large (see results), so we use standard con-
centrations of 10, 50, 100, 300 and 500 ng/mL diluted in
1% BSA-PBS from the 1 mg/mL stock solution for each
assay. In cases where the samples are not diluted by at
least 1:2, standards are prepared by diluting in 0.1 M acetic
acid rather than the 1% BSA solution. We have found that
the absorbance values for acetic acid are slightly different
than those of 1% BSA solution. Using acetic acid as the
background for samples that are not diluted compensates
for this, and does not alter the accuracy of the standard
curve. All standards, samples, and stock solutions should
be stored at -80°C between uses with little affect due to
freeze/thaw of solutions.
Assay set-up
Assays are run in 96-well microtiter plates (Nunc Maxi-
Sorp, Fisher Scientific; 439454). The first of three
controls is a blank and doesn o tr e c e i v ea n ys a m p l e ,
standard, or antibody (Figure 2). The second is a posi-
tive control that tests the efficacy of the alkaline-phos-
phatase labeled goat anti-mouse IgG+IgM (H+L)
secondary antibodies (Jackson ImmunoResearch; 115-
055-044). The third is a negative control, in which 1%
P B S - B S Ai su s e da sas a m p l ew i t hn oT T X .I nc a s e s
where acetic acid is used to prepare standards, 0.1 M
acetic acid is the negative control. This assay is very
sensitive to temperature changes and should be run at
approximately 25-30°C. We also report here, for the first
time, that small pigment molecules not excluded during
the extraction process can add to the absorbance and
thus interfere with TTX quantification. Additionally,
there may be non-specific secondary binding in some
cases, which may give false positive results. These issues
are easily circumvented by running controls of each
extract with no anti-TTX antibody to measure baseline
absorbance for each sample, which will be subtracted
from the absorbance of the quantified sample.
Assay procedures
The assay: (1) Each plate is coated with 100 μLc o n j u -
gate diluted in PBS (2 μg/mL). The plate is incubated
for one hour at room temperature (RT), and washed
three times with 250 μLo fP B S - T( 5 0 0μLT w e e n - 2 0
(Fisher Scientific; 23336-2500) per 1 L PBS) buffer using
a plate washer (Bio-Rad model 1575; may also be per-
formed by hand). (2) We next block the plate using 200
μLo f1 %P B S - B S A ,i n c u b a t ef o ro n eh ra tR T ,a n d
again wash the plate. (3) Fifty-μL of standards or sam-
ples are added to wells in triplicate. Samples should be
diluted to within the range of the standard curve (preli-
minary data may be collected to determine proper dilu-
tions). (4) Fifty-μL of anti-TTX antibodies diluted to the
optimal concentration (0.391 μg/ml in our case) are
added to all sample and standard wells except individual
extract controls, incubated one hr at RT, and washed.
(5) One hundred μL of anti-mouse IgG + IgM antibo-
dies (H + L) are added to all wells except the positive
and blank controls, incubated one hr at RT, and washed.
(6) Fifty μL of secondary antibodies are added to the
positive control wells, and 200 μLo fa1m g / m Lp N P P
solution (diluted in diethanolamine buffer: 400 mL
ddH2O, 52.22 g diethanolamine (Sigma; D8885-500 G),
adjusted to pH 9.80 with concentrated HCl, 0.051 g
MgCl2 (Fisher Scientific; AC41341-0025)) is added to all
of the wells. The plate is protected from light and incu-
bated at RT for 10 minutes. (7) The plate is then read
in a Bio-Rad xMark Microplate Spectrophotometer (any
standard absorbance reader with the appropriate filter is
sufficient) at an absorbance of 405 nm. Readings are
taken every 5 minutes following the initial 10-minute
reading.
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The mean, standard deviation, and coefficient of variation
(CV) for each of the standards are calculated. To back-
calculate standard concentrations, mean absorbance
values of the standards are plotted against the log of the
known concentration for each standard. The time frame
with the best standard predictions (least summed var-
iance from known values; usually highest r
2 value of the
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Figure 2 A typical template used for plates.E a c hs a m p l es t a r t sw i t ht h el e t t e rS .S a m p l e s run without primary antibodies are used to
eliminate any background noise caused from the sample itself.
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Page 4 of 5regression line) is selected for sample quantification. The
best time frame is usually 20-45 min. Sample values out-
side the range of the standard curve are diluted and re-
run, re-assayed as a more concentrated extract, or
reported as either below detection limit (BDL) or above
detection limit (ADL) depending on whether they fall
above or below the curve.. The concentrations for any
samples are adjusted via dilution factor. The mean value
for the negative control (BSA or acetic acid), or prefer-
ably individual extract controls, should be subtracted
from the mean values of the unknowns to eliminate
background noise for the most accurate final
concentration.
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